The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Jeremy Luban, Rachel A Sattler, Elke Mühlberger, Jason D Graci, Liangxian Cao, Marla Weetall, Christopher Trotta, Joseph M Colacino, Sina Bavari, Caterina Strambio-De-Castillia, Ellen L Suder, Yetao Wang, Veronica Soloveva, Katherine Cintron-Lue, Nikolai A Naryshkin, Mark Pykett, Ellen M Welch, Kylie O’keefe, Ronald Kong, Elizabeth Goodwin, Allan Jacobson, Slobodan Paessler, Stuart W Peltz
Virus Research, doi:10.1016/j.virusres.2020.198246
The coronavirus disease 2019 (COVID-19) pandemic has created an urgent need for therapeutics that inhibit the SARS-COV-2 virus and suppress the fulminant inflammation characteristic of advanced illness. Here, we describe the anti-COVID-19 potential of PTC299, an orally bioavailable compound that is a potent inhibitor of dihydroorotate dehydrogenase (DHODH), the rate-limiting enzyme of the de novo pyrimidine nucleotide biosynthesis pathway. In tissue culture, PTC299 manifests robust, dose-dependent, and DHODH-dependent inhibition of SARS-COV-2 replication (EC 50 range, 2.0-31.6 nM) with a selectivity index >3,800. PTC299 also blocked replication of other RNA viruses, including Ebola virus. Consistent with known DHODH requirements for immunomodulatory cytokine production, PTC299 inhibited the production of interleukin (IL)-6, IL-17A (also called IL-17), IL-17 F, and vascular endothelial growth factor (VEGF) in tissue culture models. The combination of anti-SARS-CoV-2 activity, cytokine inhibitory activity, and previously established favorable pharmacokinetic and human safety profiles render PTC299 a promising therapeutic for COVID-19.
Appendix A. Supplementary data Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10. 1016/j.virusres.2020.198246.
References
Berg, Kunkel, Hytopoulos, Characterization of compound mechanisms and secondary activities by BioMAP analysis, J. Pharmacol. Toxicol. Methods,
doi:10.1016/j.vascn.2005.06.003
Berg, Yang, Melrose, Chemical target and pathway toxicity mechanisms defined in primary human cell systems, J. Pharmacol. Toxicol. Methods,
doi:10.1016/j.vascn.2009.10.001
Berg, Yang, Polokoff, Building predictive models for mechanism-ofaction classification from phenotypic assay data sets, J. Biomol. Screen,
doi:10.1177/1087057113505324
Breedveld, Dayer, Leflunomide: mode of action in the treatment of rheumatoid arthritis, Ann. Rheum. Dis,
doi:10.1136/ard.59.11.841
Cao, Weetall, Trotta, Targeting of hematologic malignancies with PTC299, a novel potent inhibitor of dihydroorotate dehydrogenase with favorable pharmaceutical properties, Mol. Cancer Ther
Cheung, Lai, Dai, Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response, J. Gen. Virol,
doi:10.1099/jgv.0.000758
Duley, Henman, Carpenter, Elevated plasma dihydroorotate in Miller syndrome: biochemical, diagnostic and clinical implications, and treatment with uridine, Mol. Genet. Metab,
doi:10.1016/j.ymgme.2016.06.008
Fu, Cheng, Wu, Understanding SARS-CoV-2-Mediated inflammatory responses: from mechanisms to potential therapeutic tools, Virol. Sin,
doi:10.1007/s12250-020-00207-4
Gritti, Raimondi, Ripamonti, Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support, medRxiv
Kunkel, Dea, Ebens, An integrative biology approach for analysis of drug action in models of human vascular inflammation, FASEB J,
doi:10.1096/fj.04-1538fje
Kunkel, Plavec, Nguyen, Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cellbased models, Assay Drug Dev. Technol,
doi:10.1089/adt.2004.2.431
Li, Wang, Wang, Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway, Transl. Res,
doi:10.1016/j.trsl.2012.06.001
Liu, Wei, Lin, Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection, JCI Insight,
doi:10.1172/jci.insight.123158
Lu, Zhao, Li, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet,
doi:10.1016/s0140-6736(20)30251-8
Martinez, Sato, Kawai, Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis, Future Virol,
doi:10.2217/fvl.12.44
Mcnicholl, Mcnicholl, Neuraminidase inhibitors: zanamivir and oseltamivir, Ann. Pharmacother,
doi:10.1345/aph.10118
Melton, Melrose, Alajoki, Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation, PLoS One,
doi:10.1371/journal.pone.0058966
Munier-Lehmann, Vidalain, Tangy, On dihydroorotate dehydrogenases and their inhibitors and uses, J. Med. Chem,
doi:10.1021/jm301848w
Peiris, Chu, Cheng, Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study, Lancet,
doi:10.1016/s0140-6736(03)13412-5
Plotkin, Stemmer-Rachamimov, Barker 2nd, Hearing improvement after bevacizumab in patients with neurofibromatosis type 2, N. Engl. J. Med,
doi:10.1056/NEJMoa0902579
Quartuccio, Semerano, Benucci, Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome, Joint Bone Spine,
doi:10.1016/j.jbspin.2020.03.011
Ruan, Yang, Wang, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med,
doi:10.1007/s00134-020-05991-x
Russell, Moss, George, Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence, ecancermedicalscience,
doi:10.3332/ecancer.2020.1022
Sanders, Monogue, Jodlowski, Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review,
doi:10.1001/jama.2020.6019
Shah, Stepan, O'mahony, Mechanisms of skin toxicity associated with metabotropic glutamate receptor 5 negative allosteric modulators, Cell Chem. Biol,
doi:10.1016/j.chembiol.2017.06.003
Tan, Lu, Zhang, Viral kinetics and antibody responses in patients with COVID-19, medRxiv
Wang, Cao, Zhang, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res,
doi:10.1038/s41422-020-0282-0
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, Jama,
doi:10.1001/jama.2020.1585
Weetall, Davis, Elfring, Phase 1 study of safety, tolerability, and pharmacokinetics of PTC299, an inhibitor of stress-regulated protein translation, Clin. Pharmacol. Drug Dev,
doi:10.1002/cpdd.240
Wiersinga, Rhodes, Cheng, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA,
doi:10.1001/jama.2020.12839
Wu, Peng, Huang, Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China, Cell Host Microbe,
doi:10.1016/j.chom.2020.02.001
Xiong, Zhang, Li, Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2, Protein Cell,
doi:10.1007/s13238-020-00768-w
Xiong, Zhang, Li, Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-specturm antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2, Protein Cell,
doi:10.1007/s13238-020-00768-w
Xu, Han, Li, Effective treatment of severe COVID-19 patients with tocilizumab, ChinaXiv
Yao, Ye, Zhang, In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clin. Infect. Dis,
doi:10.1093/cid/ciaa237
Zhao, Yuan, Wang, Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019, Clin. Infect. Dis,
doi:10.1093/cid/ciaa344
Zheng, Zhang, Liu, Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases, medRxiv,
doi:10.1101/2020.05.07.20093286
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet,
doi:10.1016/s0140-6736(20)30566-3
DOI record:
{
"DOI": "10.1016/j.virusres.2020.198246",
"ISSN": [
"0168-1702"
],
"URL": "http://dx.doi.org/10.1016/j.virusres.2020.198246",
"alternative-id": [
"S0168170220311539"
],
"article-number": "198246",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Virus Research"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.virusres.2020.198246"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Published by Elsevier B.V."
}
],
"author": [
{
"affiliation": [],
"family": "Luban",
"given": "Jeremy",
"sequence": "first"
},
{
"affiliation": [],
"family": "Sattler",
"given": "Rachel A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Mühlberger",
"given": "Elke",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Graci",
"given": "Jason D.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Cao",
"given": "Liangxian",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Weetall",
"given": "Marla",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Trotta",
"given": "Christopher",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Colacino",
"given": "Joseph M.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bavari",
"given": "Sina",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Strambio-De-Castillia",
"given": "Caterina",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Suder",
"given": "Ellen L.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Wang",
"given": "Yetao",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Soloveva",
"given": "Veronica",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Cintron-Lue",
"given": "Katherine",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Naryshkin",
"given": "Nikolai A.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Pykett",
"given": "Mark",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Welch",
"given": "Ellen M.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "O’Keefe",
"given": "Kylie",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Kong",
"given": "Ronald",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Goodwin",
"given": "Elizabeth",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Jacobson",
"given": "Allan",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Paessler",
"given": "Slobodan",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Peltz",
"given": "Stuart W.",
"sequence": "additional"
}
],
"container-title": "Virus Research",
"container-title-short": "Virus Research",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
11,
26
]
],
"date-time": "2020-11-26T17:17:06Z",
"timestamp": 1606411026000
},
"deposited": {
"date-parts": [
[
2021,
12,
29
]
],
"date-time": "2021-12-29T03:00:28Z",
"timestamp": 1640746828000
},
"funder": [
{
"DOI": "10.13039/100000009",
"award": [
"R37AI147868",
"R01AI148784"
],
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/100000009",
"id-type": "DOI"
}
],
"name": "NIH"
},
{
"name": "Evergrande COVID-19 Response Fund Award"
},
{
"name": "Massachusetts Consortium on Pathogen Readiness"
},
{
"DOI": "10.13039/100000774",
"doi-asserted-by": "publisher",
"id": [
{
"asserted-by": "publisher",
"id": "10.13039/100000774",
"id-type": "DOI"
}
],
"name": "Defense Threat Reduction Agency"
},
{
"name": "Joint Science Technology Office"
},
{
"name": "Sponsored Research Agreement from PTC Therapeutics to University of Texas Medical Branch"
},
{
"name": "Clinical and Translational Science Award NRSA (TL1) Training Core"
}
],
"indexed": {
"date-parts": [
[
2024,
8,
26
]
],
"date-time": "2024-08-26T13:49:03Z",
"timestamp": 1724680143757
},
"is-referenced-by-count": 53,
"issued": {
"date-parts": [
[
2021,
1
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
1,
1
]
],
"date-time": "2021-01-01T00:00:00Z",
"timestamp": 1609459200000
}
},
{
"URL": "http://www.elsevier.com/open-access/userlicense/1.0/",
"content-version": "am",
"delay-in-days": 346,
"start": {
"date-parts": [
[
2021,
12,
13
]
],
"date-time": "2021-12-13T00:00:00Z",
"timestamp": 1639353600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0168170220311539?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0168170220311539?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "198246",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2021,
1
]
]
},
"published-print": {
"date-parts": [
[
2021,
1
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/j.vascn.2005.06.003",
"article-title": "Characterization of compound mechanisms and secondary activities by BioMAP analysis",
"author": "Berg",
"doi-asserted-by": "crossref",
"first-page": "67",
"issue": "1",
"journal-title": "J. Pharmacol. Toxicol. Methods",
"key": "10.1016/j.virusres.2020.198246_bib0005",
"volume": "53",
"year": "2006"
},
{
"DOI": "10.1016/j.vascn.2009.10.001",
"article-title": "Chemical target and pathway toxicity mechanisms defined in primary human cell systems",
"author": "Berg",
"doi-asserted-by": "crossref",
"first-page": "3",
"issue": "1",
"journal-title": "J. Pharmacol. Toxicol. Methods",
"key": "10.1016/j.virusres.2020.198246_bib0010",
"volume": "61",
"year": "2010"
},
{
"DOI": "10.1177/1087057113505324",
"article-title": "Building predictive models for mechanism-of-action classification from phenotypic assay data sets",
"author": "Berg",
"doi-asserted-by": "crossref",
"first-page": "1260",
"issue": "10",
"journal-title": "J. Biomol. Screen.",
"key": "10.1016/j.virusres.2020.198246_bib0015",
"volume": "18",
"year": "2013"
},
{
"DOI": "10.1136/ard.59.11.841",
"article-title": "Leflunomide: mode of action in the treatment of rheumatoid arthritis",
"author": "Breedveld",
"doi-asserted-by": "crossref",
"first-page": "841",
"issue": "11",
"journal-title": "Ann. Rheum. Dis.",
"key": "10.1016/j.virusres.2020.198246_bib0020",
"volume": "59",
"year": "2000"
},
{
"DOI": "10.1158/1535-7163.MCT-18-0863",
"article-title": "Targeting of hematologic malignancies with PTC299, a novel potent inhibitor of dihydroorotate dehydrogenase with favorable pharmaceutical properties",
"author": "Cao",
"doi-asserted-by": "crossref",
"first-page": "3",
"issue": "1",
"journal-title": "Mol. Cancer Ther.",
"key": "10.1016/j.virusres.2020.198246_bib0025",
"volume": "18",
"year": "2019"
},
{
"DOI": "10.1099/jgv.0.000758",
"article-title": "Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response",
"author": "Cheung",
"doi-asserted-by": "crossref",
"first-page": "946",
"issue": "5",
"journal-title": "J. Gen. Virol.",
"key": "10.1016/j.virusres.2020.198246_bib0030",
"volume": "98",
"year": "2017"
},
{
"DOI": "10.1016/j.antiviral.2020.104786",
"article-title": "Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro",
"author": "Choy",
"doi-asserted-by": "crossref",
"journal-title": "Antiviral Res.",
"key": "10.1016/j.virusres.2020.198246_bib0035",
"volume": "178",
"year": "2020"
},
{
"DOI": "10.1016/j.ymgme.2016.06.008",
"article-title": "Elevated plasma dihydroorotate in Miller syndrome: biochemical, diagnostic and clinical implications, and treatment with uridine",
"author": "Duley",
"doi-asserted-by": "crossref",
"first-page": "83",
"issue": "1–2",
"journal-title": "Mol. Genet. Metab.",
"key": "10.1016/j.virusres.2020.198246_bib0040",
"volume": "119",
"year": "2016"
},
{
"DOI": "10.1007/s12250-020-00207-4",
"article-title": "Understanding SARS-CoV-2-Mediated inflammatory responses: from mechanisms to potential therapeutic tools",
"author": "Fu",
"doi-asserted-by": "crossref",
"journal-title": "Virol. Sin.",
"key": "10.1016/j.virusres.2020.198246_bib0045",
"year": "2020"
},
{
"article-title": "Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support",
"author": "Gritti",
"journal-title": "medRxiv.",
"key": "10.1016/j.virusres.2020.198246_bib0050",
"year": "2020"
},
{
"DOI": "10.1038/s41591-020-0968-3",
"article-title": "Extrapulmonary manifestations of COVID-19",
"author": "Gupta",
"doi-asserted-by": "crossref",
"first-page": "1017",
"issue": "7",
"journal-title": "Nat. Med.",
"key": "10.1016/j.virusres.2020.198246_bib0055",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan",
"author": "Huang",
"doi-asserted-by": "crossref",
"first-page": "497",
"issue": "10223",
"journal-title": "China. Lancet",
"key": "10.1016/j.virusres.2020.198246_bib0060",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1016/S2213-2600(20)30216-2",
"article-title": "COVID-19 cytokine storm: the interplay between inflammation and coagulation",
"author": "Jose",
"doi-asserted-by": "crossref",
"journal-title": "Lancet Respir. Med.",
"key": "10.1016/j.virusres.2020.198246_bib0065",
"year": "2020"
},
{
"DOI": "10.1096/fj.04-1538fje",
"article-title": "An integrative biology approach for analysis of drug action in models of human vascular inflammation",
"author": "Kunkel",
"doi-asserted-by": "crossref",
"first-page": "1279",
"issue": "11",
"journal-title": "FASEB J.",
"key": "10.1016/j.virusres.2020.198246_bib0070",
"volume": "18",
"year": "2004"
},
{
"DOI": "10.1089/adt.2004.2.431",
"article-title": "Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models",
"author": "Kunkel",
"doi-asserted-by": "crossref",
"first-page": "431",
"issue": "4",
"journal-title": "Assay Drug Dev. Technol.",
"key": "10.1016/j.virusres.2020.198246_bib0075",
"volume": "2",
"year": "2004"
},
{
"DOI": "10.1016/j.trsl.2012.06.001",
"article-title": "Inhibitory effect of the antimalarial agent artesunate on collagen-induced arthritis in rats through nuclear factor kappa B and mitogen-activated protein kinase signaling pathway",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "89",
"issue": "2",
"journal-title": "Transl. Res.",
"key": "10.1016/j.virusres.2020.198246_bib0080",
"volume": "161",
"year": "2013"
},
{
"DOI": "10.1172/jci.insight.123158",
"article-title": "Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection",
"author": "Liu",
"doi-asserted-by": "crossref",
"issue": "4",
"journal-title": "JCI Insight",
"key": "10.1016/j.virusres.2020.198246_bib0085",
"volume": "4",
"year": "2019"
},
{
"DOI": "10.1016/S0140-6736(20)30251-8",
"article-title": "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding",
"author": "Lu",
"doi-asserted-by": "crossref",
"first-page": "565",
"issue": "10224",
"journal-title": "Lancet",
"key": "10.1016/j.virusres.2020.198246_bib0090",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.2217/fvl.12.44",
"article-title": "Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis",
"author": "Martinez",
"doi-asserted-by": "crossref",
"first-page": "593",
"issue": "6",
"journal-title": "Future Virol.",
"key": "10.1016/j.virusres.2020.198246_bib0095",
"volume": "7",
"year": "2012"
},
{
"DOI": "10.1345/aph.10118",
"article-title": "Neuraminidase inhibitors: zanamivir and oseltamivir",
"author": "McNicholl",
"doi-asserted-by": "crossref",
"first-page": "57",
"issue": "1",
"journal-title": "Ann. Pharmacother.",
"key": "10.1016/j.virusres.2020.198246_bib0100",
"volume": "35",
"year": "2001"
},
{
"DOI": "10.1016/j.mehy.2020.109749",
"article-title": "IL-17 have a role in COVID-19 infection?",
"author": "Megna",
"doi-asserted-by": "crossref",
"journal-title": "Med. Hypotheses",
"key": "10.1016/j.virusres.2020.198246_bib0105",
"volume": "140",
"year": "2020"
},
{
"DOI": "10.1371/journal.pone.0058966",
"article-title": "Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation",
"author": "Melton",
"doi-asserted-by": "crossref",
"first-page": "e58966",
"issue": "3",
"journal-title": "PLoS One",
"key": "10.1016/j.virusres.2020.198246_bib0110",
"volume": "8",
"year": "2013"
},
{
"DOI": "10.1126/science.abb8925",
"article-title": "Cytokine release syndrome in severe COVID-19",
"author": "Moore",
"doi-asserted-by": "crossref",
"journal-title": "Science.",
"key": "10.1016/j.virusres.2020.198246_bib0115",
"year": "2020"
},
{
"DOI": "10.1021/jm301848w",
"article-title": "On dihydroorotate dehydrogenases and their inhibitors and uses",
"author": "Munier-Lehmann",
"doi-asserted-by": "crossref",
"first-page": "3148",
"issue": "8",
"journal-title": "J. Med. Chem.",
"key": "10.1016/j.virusres.2020.198246_bib0120",
"volume": "56",
"year": "2013"
},
{
"DOI": "10.1038/s41577-020-0328-z",
"article-title": "COVID-19: a case for inhibiting IL-17?",
"author": "Pacha",
"doi-asserted-by": "crossref",
"first-page": "345",
"issue": "6",
"journal-title": "Nat. Rev. Immunol.",
"key": "10.1016/j.virusres.2020.198246_bib0125",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(03)13412-5",
"article-title": "Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study",
"author": "Peiris",
"doi-asserted-by": "crossref",
"first-page": "1767",
"issue": "9371",
"journal-title": "Lancet",
"key": "10.1016/j.virusres.2020.198246_bib0130",
"volume": "361",
"year": "2003"
},
{
"DOI": "10.1056/NEJMoa0902579",
"article-title": "Hearing improvement after bevacizumab in patients with neurofibromatosis type 2",
"author": "Plotkin",
"doi-asserted-by": "crossref",
"first-page": "358",
"issue": "4",
"journal-title": "N. Engl. J. Med.",
"key": "10.1016/j.virusres.2020.198246_bib0135",
"volume": "361",
"year": "2009"
},
{
"DOI": "10.1016/j.jbspin.2020.03.011",
"article-title": "Urgent avenues in the treatment of COVID-19: targeting downstream inflammation to prevent catastrophic syndrome",
"author": "Quartuccio",
"doi-asserted-by": "crossref",
"first-page": "191",
"issue": "3",
"journal-title": "Joint Bone Spine",
"key": "10.1016/j.virusres.2020.198246_bib0140",
"volume": "87",
"year": "2020"
},
{
"article-title": "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China",
"author": "Ruan",
"first-page": "1",
"journal-title": "Intensive Care Med.",
"key": "10.1016/j.virusres.2020.198246_bib0145",
"year": "2020"
},
{
"DOI": "10.3332/ecancer.2020.1022",
"article-title": "Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence",
"author": "Russell",
"doi-asserted-by": "crossref",
"first-page": "1022",
"journal-title": "ecancermedicalscience",
"key": "10.1016/j.virusres.2020.198246_bib0150",
"volume": "14",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.6019",
"article-title": "Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review",
"author": "Sanders",
"doi-asserted-by": "crossref",
"journal-title": "Jama.",
"key": "10.1016/j.virusres.2020.198246_bib0155",
"year": "2020"
},
{
"DOI": "10.1016/j.chembiol.2017.06.003",
"article-title": "Mechanisms of skin toxicity associated with metabotropic glutamate receptor 5 negative allosteric modulators",
"author": "Shah",
"doi-asserted-by": "crossref",
"first-page": "858",
"issue": "7",
"journal-title": "Cell Chem. Biol.",
"key": "10.1016/j.virusres.2020.198246_bib0160",
"volume": "24",
"year": "2017"
},
{
"article-title": "Viral kinetics and antibody responses in patients with COVID-19",
"author": "Tan",
"journal-title": "medRxiv.",
"key": "10.1016/j.virusres.2020.198246_bib0165",
"year": "2020"
},
{
"article-title": "COVID-19: the vasculature unleashed",
"author": "Teuwen",
"first-page": "1",
"journal-title": "Nat. Rev. Immunol.",
"key": "10.1016/j.virusres.2020.198246_bib0170",
"year": "2020"
},
{
"DOI": "10.1001/jama.2020.1585",
"article-title": "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "1061",
"issue": "11",
"journal-title": "Jama",
"key": "10.1016/j.virusres.2020.198246_bib0175",
"volume": "323",
"year": "2020"
},
{
"DOI": "10.1038/s41422-020-0282-0",
"article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "269",
"issue": "3",
"journal-title": "Cell Res.",
"key": "10.1016/j.virusres.2020.198246_bib0180",
"volume": "30",
"year": "2020"
},
{
"DOI": "10.1002/cpdd.240",
"article-title": "Phase 1 study of safety, tolerability, and pharmacokinetics of PTC299, an inhibitor of stress-regulated protein translation",
"author": "Weetall",
"doi-asserted-by": "crossref",
"first-page": "296",
"issue": "4",
"journal-title": "Clin. Pharmacol. Drug Dev.",
"key": "10.1016/j.virusres.2020.198246_bib0185",
"volume": "5",
"year": "2016"
},
{
"DOI": "10.1001/jama.2020.12839",
"article-title": "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review",
"author": "Wiersinga",
"doi-asserted-by": "crossref",
"journal-title": "JAMA.",
"key": "10.1016/j.virusres.2020.198246_bib0190",
"year": "2020"
},
{
"DOI": "10.1016/j.chom.2020.02.001",
"article-title": "Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "325",
"issue": "3",
"journal-title": "Cell Host Microbe",
"key": "10.1016/j.virusres.2020.198246_bib0195",
"volume": "27",
"year": "2020"
},
{
"DOI": "10.1038/s41586-020-2008-3",
"article-title": "A new coronavirus associated with human respiratory disease in China",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "265",
"issue": "7798",
"journal-title": "Nature",
"key": "10.1016/j.virusres.2020.198246_bib0200",
"volume": "579",
"year": "2020"
},
{
"DOI": "10.1007/s13238-020-00768-w",
"article-title": "Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-specturm antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2",
"author": "Xiong",
"doi-asserted-by": "crossref",
"first-page": "723",
"issue": "10",
"journal-title": "Protein Cell",
"key": "10.1016/j.virusres.2020.198246_bib0205",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1007/s13238-020-00768-w",
"article-title": "Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2",
"author": "Xiong",
"doi-asserted-by": "crossref",
"first-page": "723",
"issue": "10",
"journal-title": "Protein Cell",
"key": "10.1016/j.virusres.2020.198246_bib0210",
"volume": "11",
"year": "2020"
},
{
"article-title": "Effective treatment of severe COVID-19 patients with tocilizumab",
"author": "Xu",
"first-page": "V1",
"issue": "00026",
"journal-title": "ChinaXiv",
"key": "10.1016/j.virusres.2020.198246_bib0215",
"volume": "202003",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa237",
"article-title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",
"author": "Yao",
"doi-asserted-by": "crossref",
"journal-title": "Clin. Infect. Dis.",
"key": "10.1016/j.virusres.2020.198246_bib0220",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa344",
"article-title": "Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019",
"author": "Zhao",
"doi-asserted-by": "crossref",
"journal-title": "Clin. Infect. Dis.",
"key": "10.1016/j.virusres.2020.198246_bib0225",
"year": "2020"
},
{
"article-title": "Multi-omics study revealing tissue-dependent putative mechanisms of SARS-CoV-2 drug targets on viral infections and complex diseases",
"author": "Zheng",
"first-page": "2007",
"issue": "2005",
"journal-title": "medRxiv",
"key": "10.1016/j.virusres.2020.198246_bib0230",
"volume": "2020",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30566-3",
"article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
"author": "Zhou",
"doi-asserted-by": "crossref",
"first-page": "1054",
"issue": "10229",
"journal-title": "Lancet",
"key": "10.1016/j.virusres.2020.198246_bib0235",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1038/s41586-020-2012-7",
"article-title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
"author": "Zhou",
"doi-asserted-by": "crossref",
"first-page": "270",
"issue": "7798",
"journal-title": "Nature",
"key": "10.1016/j.virusres.2020.198246_bib0240",
"volume": "579",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2001017",
"article-title": "A novel coronavirus from patients with pneumonia in China, 2019",
"author": "Zhu",
"doi-asserted-by": "crossref",
"first-page": "727",
"issue": "8",
"journal-title": "N. Engl. J. Med.",
"key": "10.1016/j.virusres.2020.198246_bib0245",
"volume": "382",
"year": "2020"
}
],
"reference-count": 49,
"references-count": 49,
"relation": {
"has-preprint": [
{
"asserted-by": "object",
"id": "10.1101/2020.08.05.238394",
"id-type": "doi"
}
]
},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0168170220311539"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"special_numbering": "C",
"subject": [],
"subtitle": [],
"title": "The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "292"
}